St. Jude Renal Denervation Study Shows Promise

St. Jude Renal Denervation Study Shows Promise

Helps Lower Blood Pressure; No Serious Problems Reported

November 8, 2012
Manufacturing Group
Devices/Implants/Equipment Materials People/Facilities

Officials at St. Jude announce that the company's renal denervation system lowered blood pressure at six months.

Targeting nerves in the renal arteries leading to the kidneys, the EnligHTN I study helped patients reduce their blood pressure 28 mmHg points after 30 days. That rate was kept up after six months, according to studies. Seventy-six percent of patients responded to the therapy, with blood pressure dropping from an average of 176/96 mmHg to 150/86 mmHg. No serious problems with the device or therapy were reported.

The EngligHTN system disrupts a network of nerves that controls blood pressure, a process which has been found to reduce systolic and diastolic blood pressure, according to the Star Tribune in Minnesota.